RESUMO
BACKGROUND: Appropriate selection of implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device can be challenging in patients with left ventricular (LV) dysfunction. In this setting, limited information exists about the role of medical applications in helping physicians to choose the most useful device. METHODS: We developed a medical application that provides guidelines-based algorithms for helping doctors in decision process using the Apache Cordova application programming interface. e-CRTD App was tested in 36 consecutive patients (age 66.4 ± 8.5 years, 31 males) with diagnosis of heart failure (HF) addressed to electrophysiology laboratory for evaluation of ICD (N = 18) or CRT with defibrillator device (CRT-D; N = 18) implantation. Two separate teams evaluated each patient independently: expert electrophysiologists (Group A); cardiologists in training using the App (Group B). RESULTS: The outcomes of the clinical evaluation performed by Groups A and B were similar in 100% of patients in terms of classes of recommendations to device (Class I in eight cases, Class IIa in seven cases, Class III in the remaining 21). Surprisingly, the majority of indications from the general practitioners to cardiac device were inappropriate (N = 17 ICD, and N = 4 CRT-D, Class III); nevertheless, e-CRTD App helped Group B (nonexpert cardiologists) in excluding all these cases. CONCLUSIONS: This study describes and validates a mobile application realized to help the decision-making process in HF patients candidate to ICD/CRT-D. This application supports physicians to assess the eligibility for ICD or CRT-D according to current guidelines in patients with LV dysfunction.
Assuntos
Algoritmos , Tomada de Decisão Clínica/métodos , Desfibriladores Implantáveis/estatística & dados numéricos , Insuficiência Cardíaca/prevenção & controle , Aplicativos Móveis , Dispositivos de Terapia de Ressincronização Cardíaca/estatística & dados numéricos , Sistemas de Apoio a Decisões Clínicas , Insuficiência Cardíaca/diagnóstico , Humanos , Pessoa de Meia-Idade , Variações Dependentes do Observador , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Terapia Assistida por Computador/métodos , Resultado do Tratamento , Interface Usuário-ComputadorRESUMO
Increased oxidative stress may contribute to cancer anorexia, which could be ameliorated by antioxidant supplementation. methylcholanthrene (MCA) sarcoma-bearing Fisher rats were studied. After tumour inoculation, rats were randomly assigned to standard diet (CTR group, n = 6), or to an antioxidant-enriched diet (AOX group, n = 8). Eight more rats (STD-AOX group) switched from standard to antioxidant diet when anorexia developed. At the end of the study, food intake (FI, g/d), body weight and tumour weight (g) were recorded, and plasma samples were obtained. On day 16, anorexia has appeared only in CTR and STD-AOX animals. At the end of the study, FI in AOX animals was still higher than in the other groups (p = 0.08). No differences in body and tumour weights were observed among groups. However, hydrogen peroxide and interleukin-1ß levels were significantly reduced only in AOX rats. Data obtained suggest that early antioxidant supplementation improves cancer anorexia, ameliorates oxidative stress and reduces inflammation.
Assuntos
Anorexia/tratamento farmacológico , Antioxidantes/uso terapêutico , Suplementos Nutricionais , Ingestão de Energia/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Sarcoma/complicações , Animais , Anorexia/sangue , Anorexia/etiologia , Antioxidantes/administração & dosagem , Ácido Ascórbico/administração & dosagem , Ácido Ascórbico/uso terapêutico , Peso Corporal/efeitos dos fármacos , Dieta , Modelos Animais de Doenças , Esquema de Medicação , Peróxido de Hidrogênio/sangue , Interleucina-1beta/sangue , Masculino , Metilcolantreno , Distribuição Aleatória , Ratos Endogâmicos F344 , Sarcoma/sangue , Sarcoma/induzido quimicamente , Vitamina E/administração & dosagem , Vitamina E/uso terapêuticoRESUMO
The VIII Municipality of Rome is characterized by a high poverty rate, by the presence of many immigrant communities and by the lack of health services available to vulnerable social groups. In 2005 , the " Servizio di Medicina Solidale" of the University Hospital of "Tor Vergata", for the first time intervened in this Municipality regarding Immigrant Health. The paper describes the activities and organization of this service from January 2005 to December 2007. It demonstrates a complex epidemiological picture of 2,374 immigrants, characterized by a young population, mostly women with reproductive health issues, followed by children with infectious and nutritional problems and, ultimately, adults who accessed the service, firstly for gastroenterological problems, secondly for cardiovascular problems and finally for dysmetabolic disorders. The paper describes the culture-centered actions of Health Promotion and Health Education in order to improve health awareness and promote integration of immigrants. The study indicates that the limited number of hospital admissions ( n.20) with respect to the number of outpatient visits (n.70.000) in the first seven years of the service " Medicina Solidale" has significantly reduced the number of unnecessary admissions to emergency wards. In conclusion it is notable that the cost of such intervention results eight times inferior to emergency admissions and further confirms that a Community medicine approach is sustainable.
Assuntos
Atenção à Saúde , Emigrantes e Imigrantes , Promoção da Saúde , Adolescente , Adulto , Criança , Pré-Escolar , Atenção à Saúde/estatística & dados numéricos , Feminino , Promoção da Saúde/estatística & dados numéricos , Hospitais Universitários , Humanos , Lactente , Recém-Nascido , Masculino , Cidade de Roma , Adulto JovemRESUMO
BACKGROUND: HIV-infected children have less access to combination antiretroviral therapy as compared with adults in resource-limited settings. Growth faltering, loss to follow-up (LTFU) and high mortality are frequently seen. METHODS: A retrospective cohort study was performed with parameters extracted from the Drug Resource Enhancement against AIDS and Malnutrition database for HIV-infected, antiretroviral naïve children under 15 years presenting for care at 17 Drug Resource Enhancement against AIDS and Malnutrition centers in Mozambique, Malawi and Guinea between January 2005 to December 2008. Predictors of time-to-death, time-to-LTFU and persistence of malnutrition by Cox's regression and Kaplan-Meier were determined. RESULTS: 2215 children presented to care with 1343 (61%) being ≤ 5 years. At baseline, stunting and malnutrition occurred in 40% and 25%, respectively; 75% of 2149 children had CD4 cell percentages less than 20; median HIV RNA, log10 cp/mL, was 4.97 in 1927 patients. Over time 238 children died (10.7%; 2.7% person-years [PY]) 63 were LTFU (2.8%; 0.7% PY). By multivariate analysis, mortality was associated with virus load (hazards ratio: 1.19; confidence interval: 1.01-1.402, P = 0.038) and reduced weight-for-age Z scores (hazards ratio: 0.590; confidence interval: 0.53-0.66, P < 0.001). LTFU was associated with low weight-for-height Z scores (hazards ratio: 0.71; confidence interval: 0.51-0.97, P = 0.031). At 12 months after combination antiretroviral therapy, anthropometric parameters significantly improved in 1226 children (P < 0.001); virus load declined to <400 copies/mL in over 60%. CONCLUSIONS: Despite advanced HIV disease, children initiating combination antiretroviral therapy had mortality rates of 2.7% p/PY with overall attrition rates of 11.7% p/100 PY, with significant reversal of negative anthropometric markers, and improvement of immunological and virological parameters in children with 12 months of follow-up.
Assuntos
Infecções por HIV , Adolescente , África Subsaariana/epidemiologia , Antirretrovirais/uso terapêutico , Estatura , Peso Corporal , Criança , Pré-Escolar , Quimioterapia Combinada , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Infecções por HIV/mortalidade , Humanos , Lactente , Recém-Nascido , Estimativa de Kaplan-Meier , Masculino , Desnutrição , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , TuberculoseRESUMO
The GLP-1 receptor agonist exenatide has been approved for adjunctive treatment of type 2 diabetes. Continuous GLP-1 infusion improves endothelial function in vivo; no evidence about a beneficial effect of exenatide on vascular function has been published. The aim of our observational study was to evaluate whether exenatide would improve brachial artery function evaluated by the flow mediated dilation (FMD) technique, compared with glimepiride, in subjects with type 2 diabetes. FMD time course was assessed by ultrasound, after 5 min forearm ischaemia, at baseline and after 16-week treatment. At the end of the study FMD was significantly higher in subjects who assumed exenatide compared with glimepiride (9.1 ± 3.6 vs. 5.6 ± 1.0, p = 0.01). Even if limited by the small number of studied subjects, who were not matched in the two treatment groups, this research study represents the first FMD evidence suggesting that chronic administration of exenatide improves arterial dilation.
Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Endotélio Vascular/efeitos dos fármacos , Hipoglicemiantes/uso terapêutico , Peptídeos/uso terapêutico , Vasodilatação/efeitos dos fármacos , Peçonhas/uso terapêutico , Idoso , Velocidade do Fluxo Sanguíneo/fisiologia , Artéria Braquial/diagnóstico por imagem , Artéria Braquial/efeitos dos fármacos , Diabetes Mellitus Tipo 2/diagnóstico por imagem , Diabetes Mellitus Tipo 2/fisiopatologia , Quimioterapia Combinada , Eletrocardiografia , Endotélio Vascular/fisiopatologia , Exenatida , Feminino , Receptor do Peptídeo Semelhante ao Glucagon 1 , Humanos , Masculino , Metformina/uso terapêutico , Pessoa de Meia-Idade , Receptores de Glucagon/agonistas , Compostos de Sulfonilureia/uso terapêutico , Ultrassonografia Doppler , Vasodilatação/fisiologiaRESUMO
Infant malnutrition in sub-Saharan Africa is a public health priority and a challenge in high HIV prevalence areas. The Drug Resources Enhancement Against AIDS and Malnutrition program, with multiple medical centers in Sub-Saharan Africa, developed an innovative intervention for the surveillance and control of malnutrition. In a pilot initiative, 36 HIV-exposed children were evaluated at baseline upon presentation for malnutrition and at six months post- treatment. Parameters included HIV-free survival, nutritional status and change in diet. Food diary data was entered and processed using the Nutrisurvey (WHO) software. At 6 months post-intervention, a significant improvement in anthropometric parameters was noted. Slowing of linear growth was observed in patients with malaria with a mean gain in centimetres of 4.4 ± 1.7 as compared to 5.6 ± 1.7 in children with no malaria, p < 0.048 (CL 95%: -2.32, -0.01). Dietary diversity scores increased from 5.3 ± 1.9 to 6.5 ± 1.3, p < 0.01 at 6 months. A significant increase (+25%, p < 0.02) in the number of children eating fish meals was noted. Our pilot data describes positive outcomes from a rehabilitative nutritional approach based on use of local foods, peer education, anthropometric and clinical monitoring in areas of high food insecurity. The relationship between malaria and linear growth retardation requires further investigation.